Picture of Psyence logo

PSYG Psyence Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Psyence, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:10 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.3-4.6-6.08-69.4-0.03
Depreciation
Non-Cash Items9.170.9550.40664.9-4.94
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.1170.0331.94-0.487-0.584
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-2.2-3.56-3.64-4.92-5.55
Capital Expenditures-0.376-0.164-0.264-0.988-0.014
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.004-0.147-0.166-0.002-0.002
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.373-0.311-0.43-0.99-0.015
Financing Cash Flow Items-0.03402.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities8.671.272.964.5813.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6.1-2.6-1.11-1.327.83